News for Healthier Living

The Lancet Publishes Landmark Trial of Duchenne Muscular Dystrophy Therapy

An investigational cell therapy preserved heart and muscle function in boys and young men with Duchenne muscular dystrophy, according to Phase III clinical trial results from Cedars-Sinai Health Sciences University investigators and colleagues published in The Lancet.

July 29, 2026


August 1 2026

July 31 2026

July 30 2026

July 29 2026

July 28 2026

July 27 2026

July 26 2026

July 25 2026

July 24 2026

July 23 2026

July 22 2026

July 21 2026

July 20 2026